First, the strain of virus must be isolated and vaccine produced in sufficient quantities for distribution. However, improved cell culture techniques in vaccine manufacture have decreased the preparation time compared with traditional egg-based technology.54 Second, the ability to perform safety and ...
9,10 Text messaging is a novel approach to increase influenza vaccine coverage. It can be used for large populations at low cost, especially when linked to immunization registries and electronic health record (EHR) systems. Families appear to be interested in text message vaccine reminders, ...
<Reference> One case of swine flu reported in Homer DHHS defines a pandemic flu as a global outbreak of an influenza virus for which people have little or no immunity, and for which a vaccine may not have … http://www.homernews.com/stories/061809/news_3_001.shtml June 19, 2009 Homer...
“live” vaccine, ie, attenuated (prepared from viruses adapted to a reduced replication temperature) has been used. The so-called “viva” vaccine is intended to actively immunize healthy children and adolescents aged 24 months to 17 years of age. The preparation is in the form of aerosol ...
Chin2, George Carnell4, Nigel Temperton4, Raghavan Varadarajan3 & Leo L. M. Poon2 Inaccuracies in prediction of circulating viral strain genotypes and the possibility of novel reassortants causing a pandemic outbreak necessitate the development of an anti-influenza vaccine with ...
29 CDC. Update: influenza activity — United States and worldwide, 2002–03 season, and composition of the 2003–04 influenza vaccine. MMWR Morb Morta Wkly Rep 2003; 52: 516–21. 30 Peiris M, Yam WC, Chan KH, Ghose P, Shortridge KF. Influenza A H9N2: aspects of laboratory diagnosis....
record for Vero cell-derived vaccines for human use. In October 2009, a Vero cell-based vaccine to the novel pandemic H1N1 virus was developed and licensed in Europe (http://www.baxter.com/press_room/press_releases/2009/10_07_09-celvapan.html). One MDCK cell-derived vaccine has been ...
A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine.2002;20:1831-1836.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11906772&dopt=...
Where a vaccine includes more than one strain of influenza, the different strains are typically grown separately and are mixed after the viruses have been harvested and antigens have been prepared. Thus a process of the invention may include the step of mixing antigens from more than one ...
The antigen will generally be in an aqueous form, such that the vaccine is finally prepared by mixing two liquids. The volume ratio of the two liquids for mixing can vary (e.g. between 5:1 and 1:5) but is generally about 1:1. After the antigen and adjuvant have been mixed, ...